CMS(867.HK/8A8.SG):Ruxolitinib Phosphate Cream (Lumirix®) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
· china medical system holdings ltd.
AI Briefing
- Ruxolitinib phosphate cream (Lumirix) achieves initial prescriptions in 30 provincial-level regions in China for patients with vitiligo.
- The prescriptions cover over 1,000 medical institutions, including prominent hospitals and drugstores.
- Product available via over 1,300 offline drugstores and JD.com e-commerce platform.
Advertisement